| Annual Financials | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 18 | 28 | 30 | 44 | 41 | 8 |
| Expenses | 19 | 24 | 26 | 27 | 29 | 6 |
| EBITDA | -1 | 4 | 4 | 17 | 12 | 2 |
| Operating Profit % | -6 % | 13 % | 14 % | 38 % | 29 % | 6 % |
| Depreciation | 0 | 0 | 0 | 0 | 1 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -1 | 3 | 4 | 17 | 12 | 2 |
| Tax | 0 | 1 | 1 | 4 | 1 | 1 |
| Net Profit | -1 | 3 | 3 | 13 | 11 | 2 |
| EPS in ₹ | -0.64 | 1.65 | 2.00 | 8.01 | 6.63 | 299.20 |
Amwill Health Care
Amwill Health Care
55.83
+1.83
(3.39%)
There are 3 new updates from the company11 hours ago
Show All
Key Fundamentals
Market Cap
108.00 Cr
EPS
6.63
PE Ratio
10.42
Dividend Yield
0.00 %
Industry
-52 Week High
104.90
52 Week Low
50.00
PB Ratio
1.61
Debt to Equity
0.00
Sector
-Actual
Company News
View All News
Amwill Healthcare Limited reported unaudited financial results for the half year ended September 30, 2025. The company's profit declined to Rs 387.40 lakhs compared to Rs 651.66 lakhs in the previous corresponding period. Revenue from operations decreased to Rs 2,120.50 lakhs from Rs 2,315.60 lakhs. Total expenses rose to Rs 1,733.90 lakhs from Rs 1,449.89 lakhs, with employee benefit expenses increasing significantly to Rs 424.37 lakhs from Rs 348.97 lakhs. Earnings per share dropped to Rs 1.94 from Rs 4.18. The company has utilized Rs 3,288.09 lakhs of its IPO proceeds of Rs 4,888.00 lakhs, with Rs 1,599.91 lakhs remaining unutilized. The unutilized funds are invested in term deposits and current bank accounts.
Amwill Healthcare Reports No Deviation in IPO Fund Utilization for Half-Year Ended September 2025
11 hours ago
11 hours agoAmwill Healthcare Limited confirmed no deviation or variation in the utilization of IPO proceeds from stated objectives for the half-year ended September 30, 2025. The company raised funds through equity shares with original allocations of Rs. 2,500 lakhs for working capital requirements, Rs. 500 lakhs for marketing and brand building activities, Rs. 1,218.34 lakhs for general corporate purposes, and Rs. 669.66 lakhs for issue expenses. As of September 30, 2025, the company utilized Rs. 1,227.63 lakhs for working capital, Rs. 240.77 lakhs for marketing activities, Rs. 1,150.02 lakhs for general corporate purposes, and Rs. 669.66 lakhs for issue expenses. Unutilized IPO proceeds of Rs. 1,546.61 lakhs are invested in term deposits with a bank, and Rs. 53.30 lakhs are kept in current account for intended purposes. The Audit Committee reviewed the fund utilization statement at its meeting held on November 04, 2025.
Amwill Health Care has announced an expansion of its business operations into several important markets across India. The company is extending its presence into Maharashtra, Tamil Nadu, North East India, Chhattisgarh, and Madhya Pradesh. This move signifies a strategic geographical expansion for the healthcare company.
Growth Rate
Revenue Growth
-6.77 %
Net Income Growth
-14.40 %
Cash Flow Change
281.70 %
ROE
-78.72 %
ROCE
-82.17 %
EBITDA Margin (Avg.)
-22.04 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 8 | 7 | 12 | 19 | 72 |
| Fixed Assets | 1 | 0 | 1 | 1 | 1 |
| Current Assets | 7 | 6 | 11 | 18 | 22 |
| Capital Work in Progress | 0 | 0 | 0 | 1 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8 | 6 | 12 | 18 | 70 |
| Total Liabilities | 8 | 7 | 12 | 19 | 72 |
| Current Liabilities | 9 | 5 | 8 | 2 | 2 |
| Non Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Equity | -1 | 2 | 5 | 17 | 69 |
| Reserve & Surplus | -1 | 2 | 5 | 17 | 49 |
| Share Capital | 0 | 0 | 0 | 0 | 20 |
Cash Flow
| Cash Flow | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 3 | 3 | -5 | 1 |
| Investing Activities | -1 | -0 | -1 | -1 | -46 |
| Operating Activities | 0 | 3 | 5 | -3 | 6 |
| Financing Activities | 0 | 0 | -0 | 0 | 41 |
Share Holding
| % Holding | May 2024 | Jan 2025 | Feb 2025 | Mar 2025 | Sept 2025 |
| Promoter | 97.00 % | 97.00 % | 97.00 % | 70.65 % | 70.65 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 1.16 % | 1.16 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 0.00 % | 21.14 % | 24.85 % |
| Others | 3.00 % | 3.00 % | 3.00 % | 7.05 % | 3.34 % |
| No of Share Holders | 7 | 7 | 7 | 1,374 | 1,606 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 04 Nov 2025 |  Quarterly Result Announcement | NA | 04 Nov 2025 | 50.70 | 54.00 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 83.99 | 84.46 |
| 14 Aug 2025 |  Annual General Meeting | NA | 14 Aug 2025 | 67.06 | 63.00 |
Announcements
SUBMISSION OF STATEMENT OF DEVIATION OR VARIATION IN UTILIZATION OF FUNDS RAISED THROUGH INITIAL PUBLIC OFFER (IPO")11 hours ago
11 hours agoUnaudited Financial Results For The Half Year Ended September 30 2025.11 hours ago
11 hours agoBoard Meeting Outcome for
Board Meeting Outcome For The Meeting Of The Board Of Directors Held On November 04 2025
11 hours ago
11 hours agoBoard Meeting Intimation for For Convening The Board Meeting On Thursday October 30 2025 For Consideration And Approval Of Unaudited Financial Results For H1 FY26 Has Been Rescheduled And Will Now Be Held On Tuesday November 04 2025.5 days ago
5 days agoBoard Meeting Intimation for Convening The Board Meeting On Thursday October 30 2025 For Consideration And Approval Of Unaudited Financial Results For H1 FY26.Oct 24, 2025
Oct 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Oct 10, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 14, 2025
Aug 14, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 20, 2025
Jul 20, 2025Reg. 34 (1) Annual Report.Jul 18, 2025
Jul 18, 2025Notice Of 08Th Annual General Meeting And Annual Report For FY 2024-25Jul 18, 2025
Jul 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2025
Jul 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 2025Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On July 08 2025Jul 08, 2025
Jul 08, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 30, 2025
Jun 30, 2025SUBMISSION OF STATEMENT OF DEVIATION OR VARIATION IN UTILIZATION OF FUNDS RAISED THROUGH INITIAL PUBLIC OFFER (IPO")May 29, 2025
May 29, 2025Audited Financial Results For The Half Year And Year Ended March 31 2025.May 29, 2025
May 29, 2025Board Meeting Outcome for Board Meeting Intimation To Consider And Approve The Half Year And Yearly Audited Financial Results Of The Company For The Period Ended March 31St 2025.May 29, 2025
May 29, 2025Board Meeting Intimation for Board Meeting Intimation For Audited Financial Results For Half Yeraly And Yearly For The Period Ened March 31 2025 Of The Company.May 26, 2025
May 26, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 14, 2025
May 14, 2025Appointment Of Mr. Syed Shahabuddin (Cop:11932) Practicing Company Secretary Peer Review Certificate No. 3387/2023 As The Secreterial Auditor Of The Company For Financial Year 2024-25.May 09, 2025
May 09, 2025Announcement Under Regulation 30 (LODR)Apr 16, 2025
Apr 16, 2025Announcement Under Regulation 30(LODR)_( Appointment Of Internal Auditor FY 2024-25)Apr 16, 2025
Apr 16, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 16, 2025
Apr 16, 2025Appointment of Company Secretary and Compliance OfficerApr 10, 2025
Apr 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Apr 07, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 03, 2025
Apr 03, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 02, 2025
Apr 02, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 20, 2025
Feb 20, 2025Listing of Equity Shares of Amwill Health Care LtdFeb 12, 2025
Feb 12, 2025Technical Indicators
RSI(14)
Neutral 55.20
ATR(14)
Less Volatile 1.99
STOCH(9,6)
Neutral 68.94
STOCH RSI(14)
Overbought 82.06
MACD(12,26)
Bullish 0.52
ADX(14)
Weak Trend 20.54
UO(9)
Bearish 49.85
ROC(12)
Uptrend And Accelerating 7.37
WillR(14)
Overbought -2.83
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
